Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model
- 1Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
- 2Universidad de Costa Rica, Montes de Oca, San José, Costa Rica
Related
- Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
- Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple‐negative breast cancer
- Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events
- TALAVE in Breast Cancer: BRCA1/2 Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement
- Real-world utilization of immune checkpoint inhibitors in medicare-eligible patients with triple-negative breast cancer in the United States
BibTeX
@article{mora2026proinflammatory,
title = {{400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model}},
author = {Javier Mora and Fiorella Calderón-Milán and Lucia Figueroa-Protti},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0400},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0400},
note = {CC BY},
}
RIS
TY - JOUR
TI - 400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model
AU - Javier Mora
AU - Fiorella Calderón-Milán
AU - Lucia Figueroa-Protti
PY - 2026
DA - 2026/11/04
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0400
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0400
SN - 2051-1426
ER -